A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials.
2021
Oncologic imaging in clinical drug trials provides acceptable markers of future response to treatment, which allows shortening the clinical trial length compared with use of standard measures of su...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
36
References
0
Citations
NaN
KQI